View of 31. Survival outcomes and prognostic factors of paclitaxel - carboplatin chemotherapy for the treatment of metastatic non-small cell lung cancer acquired resisted to first- and second-generations of EGFR tyrosine kinase inhibitors

Return to Article Details 31. Survival outcomes and prognostic factors of paclitaxel - carboplatin chemotherapy for the treatment of metastatic non-small cell lung cancer acquired resisted to first- and second-generations of EGFR tyrosine kinase inhibitors Download Download PDF